Masking epistasis between MYC and TGF-β pathways in antiangiogenesis-mediated colon cancer suppression

Michael Dews1, Grace S Tan, Stacy Hultine

  • 1Affiliations of authors: Division of Cancer Pathobiology, Center for Childhood Cancer Research (MD, GST, SH, AT-T) and Center for Biomedical Informatics (PR), Children's Hospital of Philadelphia, Philadelphia, PA; Cancer Biology Graduate Program (JC, EKD, AT-T) and Department of Pathology & Laboratory Medicine (AT-T), Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA; Division of Experimental Pathology, Beth Israel Deaconess Medical Center (JL) and Department of Medical Oncology, Dana-Farber Cancer Institute (AB), Harvard Medical School, Boston, MA.

Abstract

Insights

Myc and TGF-β pathways interact in colorectal cancer (CRC). Activating Myc or inactivating TGF-β similarly boosts tumor growth, showing functional redundancy in CRC development.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Genetics

Background:

  • Colorectal cancer (CRC) frequently involves c-Myc activation and TGF-β pathway dysfunction.
  • Canonical models place Myc downstream of TGF-β, but Myc can also inhibit TGF-β via microRNAs.
  • The functional relationship between Myc and TGF-β in CRC remains unclear.

Purpose of the Study:

  • To investigate the functional relationship between Myc and TGF-β signaling in colorectal cancer.
  • To determine if Myc and TGF-β pathway alterations interact or are redundant in CRC tumorigenesis.

Main Methods:

  • Engineered murine and human CRC cell lines with inducible Myc and TGF-β pathway manipulation.
  • Utilized retroviral expression of Myc-estrogen receptor fusion and Smad4 short hairpin RNA.
  • Analyzed tumor growth, neovascularization in vivo, and mutation distribution in human CRC samples (Cancer Genome Atlas).

Main Results:

  • Myc activation or TGF-β inactivation independently increased tumor size and microvascular density in murine colonocytes (1.5-2.5 fold).
  • Combined Myc activation and TGF-β inactivation showed no additive effect, indicating functional redundancy.
  • Human CRC data revealed mutually exclusive alterations between Myc overexpression and Smad inactivation (odds ratio < 0.1).

Conclusions:

  • Gain-of-function alterations in Myc and loss-of-function alterations in TGF-β exhibit a masking epistatic interaction in human CRC.
  • These two pathways are functionally redundant in driving colorectal cancer progression.

Related Concept Videos

TGF - &#946; Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.9K